Accucaps Invests $5 million in New Specialty Products Suite. Will Result in New Jobs and more R&D opportunities

From left to right: Tom Breshamer, Bill Boston, Petur Regnier, Bruno Biscaro and Larry Cichon at the Accucaps SPS Ribbon Cutting Ceremony. (CNW Group/Accucaps Industries Limited)

WINDSOR, ON, March 27, 2014 /CNW/ - Accucaps, a soft gelatin capsule contract development and manufacturing organization, recently held its grand opening ribbon cutting ceremony for its brand new multimillion-dollar Specialty Products Suite at its Windsor, Ontario facility. This milestone was an important announcement for Accucaps because it places Accucaps at the forefront of the pharmaceutical industry.  When at full capacity, this suite will employ over 20 people in production and R&D. "This investment strongly positions Accucaps as one of a very limited number of businesses with the capability to research, develop and manufacture innovative high potency pharmaceutical products that help to treat some of the most chronic diseases you, your families and the world at large face", said Bruno Biscaro, President of Accucaps.

The segregated and contained Specialty Products Suite was designed and implemented with new engineering controls, processes and procedures so that Accucaps can confidently work with these highly potent active ingredients in a safe and effective manner for both research and development activities as well as for commercial production.

"I am confident that this facility and the great people who will operate it will serve to anticipate and fulfill the needs of our customers, support our future endeavors and promote the further development of Accucaps as a leading soft gel supplier," said Bruno Biscaro.

Accucaps will be utilizing this technology to develop and produce products for Canada and for the rest of the world, including those which assist in the treatment of cancer.  Over the next few weeks, the Specialty Products Suite team will produce the company's first ever commercial high potency product.

About Accucaps: Accucaps is a world leading, innovative, research-based pharmaceutical organization that develops and supplies value-added soft gel pharmaceutical, dietary supplement and cosmetic products. They have established an industry leading team of R&D professionals focused solely on the development of products utilizing soft gelatin dosing technology and have expanded its manufacturing and supply capacity through numerous investments with the company's Windsor and Strathroy Ontario locations.

SOURCE Accucaps Industries Limited

Image with caption: "From left to right: Tom Breshamer, Bill Boston, Petur Regnier, Bruno Biscaro and Larry Cichon at the Accucaps SPS Ribbon Cutting Ceremony. (CNW Group/Accucaps Industries Limited)". Image available at: http://photos.newswire.ca/images/download/20140327_C7258_PHOTO_EN_38361.jpg

For further information:


on Accucaps Industries Limited, please visit www.accucaps.com.

Contact info
Jackie DeMartin - HR Administrator, Communications
519-969-5404 ext. 3660
jdem@accucaps.com